Volume 10, Issue 2 (6-2022)                   JoMMID 2022, 10(2): 93-97 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Maleki A, Pouriayevali M H, Tavakoli M, Ahmadi Z, Niknam Oskouei F, Nejatipour Z, et al . Sequential HCoV-HKU1 and SARS-CoV-2 Infections, a Case Report. JoMMID 2022; 10 (2) :93-97
URL: http://jommid.pasteur.ac.ir/article-1-459-en.html
COVID-19 National Reference Laboratory, Pasteur Institute of Iran, Tehran, Iran; Department of Arboviruses and Viral Hemorrhagic Fevers (National Reference Laboratory), Pasteur Institute of Iran, Tehran, Iran
Abstract:   (1133 Views)
In the SARS-CoV-2 pandemic, the seasonal viral respiratory infections had a minimum prevalence due to public health precautions to reduce the risk of getting Coronavirus Disease 19 (COVID-19). There have been reports of COVID-19 coinfection with influenza, respiratory syncytial virus (RSV), and seasonal coronaviruses during the pandemic. Here, we report a case in which the patient had sequential respiratory infections of human coronavirus HKU1 (HCoV-HKU1) and SARS-CoV-2 in a fully vaccinated, healthy person. It should be noted that other seasonal coronaviruses that could cause symptomatic RTIs might be misdiagnosed clinically with COVID-19. Hence, we highly recommend monitoring and follow-up of symptomatic patients with negative SARS-COV-2 RT-PCR results.
 
Full-Text [PDF 728 kb]   (586 Downloads)    
Type of Study: Case Report | Subject: Infectious diseases and public health
Received: 2022/04/20 | Accepted: 2022/06/11 | Published: 2022/06/8

References
1. Salehi-Vaziri M, Fazlalipour M, Seyed Khorrami SM, Azadmanesh K, Pouriayevali MH, Jalali T, et al. The ins and outs of SARS-CoV-2 variants of concern (VOCs). Arch Virol. 2022; 167 (2): 327-44. [DOI:10.1007/s00705-022-05365-2]
2. Harvey WT, Carabelli AM, Jackson B, Gupta RK, Thomson EC, Harrison EM, et al. SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol. 2021; 19 (7): 409-24. [DOI:10.1038/s41579-021-00573-0]
3. Edridge AWD, Kaczorowska J, Hoste ACR, Bakker M, Klein M, Loens K, et al. Seasonal coronavirus protective immunity is short-lasting. Nat Med. 2020; 26 (11): 1691-3. [DOI:10.1038/s41591-020-1083-1]
4. Chaung J, Chan D, Pada S, Tambyah PA. Coinfection with COVID-19 and coronavirus HKU1-The critical need for repeat testing if clinically indicated. J Med Virol. 2020; 92 (10): 1785-6. [DOI:10.1002/jmv.25890]
5. Kanwar A, Selvaraju S, Esper F. Human Coronavirus-HKU1 Infection Among Adults in Cleveland, Ohio. Open Forum Infect Dis. 2017; 4 (2): ofx052. [DOI:10.1093/ofid/ofx052]
6. Dadashi M, Khaleghnejad S, Abedi Elkhichi P, Goudarzi M, Goudarzi H, Taghavi A, et al. COVID-19 and Influenza Co-infection: A Systematic Review and Meta-Analysis. Front Med. 2021; 8: 681469. [DOI:10.3389/fmed.2021.681469]
7. Koutsakos M, Wheatley AK, Laurie K, Kent SJ, Rockman S. Influenza lineage extinction during the COVID-19 pandemic? Nat Rev Microbiol. 2021; 19 (12): 741-2. [DOI:10.1038/s41579-021-00642-4]
8. Groves HE, Piché-Renaud P-P, Peci A, Farrar DS, Buckrell S, Bancej C, et al. The impact of the COVID-19 pandemic on influenza, respiratory syncytial virus, and other seasonal respiratory virus circulation in Canada: A population-based study. Lancet Reg Health Am. 2021; 100015. [DOI:10.1016/j.lana.2021.100015]
9. Salehi-Vaziri M, Arashkia A, Mostafavi E, Jalali T, Pouriayevali MH, Fazlalipour M, et al. How Iran responded to expanding need for laboratory services for COVID-19? Health Policy Technol. 2021; 10 (2): 100506. [DOI:10.1016/j.hlpt.2021.100506]
10. Ljubin-Sternak S, Meštrović T, Lukšić I, Mijač M, Vraneš J. Seasonal Coronaviruses and Other Neglected Respiratory Viruses: A Global Perspective and a Local Snapshot. Front Public Health. 2021; 9: 691163. [DOI:10.3389/fpubh.2021.691163]
11. Mansuy J-M, Bourcier M, Trémeaux P, Dimeglio C, Izopet J. COVID-19 pandemic period, where are the seasonal viruses? J Med Virol. 2021; 93 (7): 4097-8. [DOI:10.1002/jmv.26959]
12. Wu D, Liu Q, Wu T, Wang D, Lu J. The impact of COVID-19 control measures on the morbidity of varicella, herpes zoster, rubella and measles in Guangzhou, China. Immun Inflamm Dis. 2020; 8 (4): 844-6. [DOI:10.1002/iid3.352]
13. Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens. JAMA. 2020; 323 (20): 2085-6. [DOI:10.1001/jama.2020.6266]
14. Dugas M, Grote-Westrick T, Vollenberg R, Lorentzen E, Brix T, Schmidt H, et al. Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1). Int J Infect Dis. 2021; 105: 304-6. [DOI:10.1016/j.ijid.2021.02.085]
15. Yin Z, Kang Z, Yang D, Ding S, Luo H, Xiao E. A Comparison of Clinical and Chest CT Findings in Patients With Influenza A (H1N1) Virus Infection and Coronavirus Disease (COVID-19). AJR Am J Roentgenol. 2020; 215 (5): 1065-71. [DOI:10.2214/AJR.20.23214]
16. Baek MS, Cha MJ, Kim M-C, Chung J-W, Kim W-Y, Choi H, et al. Clinical and radiological findings of adult hospitalized patients with community-acquired pneumonia from SARS-CoV-2 and endemic human coronaviruses. PLoS One. 2021; 16 (1): e0245547. [DOI:10.1371/journal.pone.0245547]
17. Altmayer S, Zanon M, Pacini GS, Watte G, Barros MC, Mohammed T-L, et al. Comparison of the computed tomography findings in COVID-19 and other viral pneumonia in immunocompetent adults: a systematic review and meta-analysis. Eur Radiol. 2020; 30 (12): 6485-96. [DOI:10.1007/s00330-020-07018-x]
18. Jackson B, Boni MF, Bull MJ, Colleran A, Colquhoun RM, Darby AC, et al. Generation and transmission of interlineage recombinants in the SARS-CoV-2 pandemic. Cell. 2021; 184 (20): 5179-88. [DOI:10.1016/j.cell.2021.08.014]
19. Sawicki SG, Sawicki DL. Coronaviruses use discontinuous extension for synthesis of subgenome-length negative strands. Adv Exp Med Biol. 1995; 380: 499-506. [DOI:10.1007/978-1-4615-1899-0_79]
20. WHO. Update on Omicron 2021 [Available from: https://www.who.int/news/item/28-11-2021-update-on-omicron.
21. Venkatakrishnan A, Anand, P., Lenehan, P., Suratekar, R., Raghunathan, B., Niesen, M. J., & Soundararajan, V. Omicron variant of SARS-CoV-2 harbors a unique insertion mutation of putative viral or human genomic origin. Preprint. 2021, December 3. [DOI:10.31219/osf.io/f7txy]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.